Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of the modified Conjunctival
Allergen Challenge (CAC) and observe how the produced allergic inflammation reacts to
treatment with a proven ocular anti-inflammatory medication,
Prednisolone, assessed by the following measures:
Chronic Allergic Inflammation assessed using confocal microscopy Ocular itching Conjunctival
redness